Company news from the 10/03/06 News Brief  Share this article:
TAP Pharmaceutical Products has agreed to a co-promotion
agreement with Novartis Pharmaceuticals Corporation for Famvir
(famciclovir), an oral antiviral prescription medication. Under
the terms of the agreement, TAP will be responsible for
promoting Famvir to the obstetrician/gynecology (OB/GYN) medical
community. Financial terms of the agreement were not disclosed.
Share this article:   Email Newsletters